BackgroundA considerable challenge in quantification of the antimalarial piperaquine in plasma is carryover of analyte signal between assays. Current intensive pharmacokinetic studies often rely on the merging of venous and capillary sampling. Drug levels in capillary plasma may be different from those in venous plasma, Thus, correlation between capillary and venous drug levels needs to be established.MethodsLiquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) was used to develop the method. Piperaquine was measured in 205 pairs of capillary and venous plasma samples collected simultaneously at ≥24hr post dose in children, pregnant women and non-pregnant women receiving dihydroartemisinin-piperaquine as malaria chemopreven...
The population pharmacokinetics of piperaquine in adults and children with uncomplicated Plasmodium ...
The population pharmacokinetics of piperaquine in adults and children with uncomplicated Plasmodium ...
One promising new Artemisinin-based combination therapies (ACTs) is dihydroartemisinin-piperaquine (...
BackgroundA considerable challenge in quantification of the antimalarial piperaquine in plasma is ca...
Purpose Dihydroartemisinin-piperaquine (DP) is a fixeddose artemisinin-based combination treatment. ...
PURPOSE: Dihydroartemisinin-piperaquine (DP) is a fixed-dose artemisinin-based combination treatment...
Piperaquine (PQ) is an antimalarial drug that is highly protein-bound. Variation in plasma protein c...
Malaria is one of the most common parasitic diseases in the world, with up to three million deaths a...
Dihydroartemisinin-piperaquine is being increasingly used as a first-line artemisinin combination tr...
Antimalarial piperaquine (PQ) is currently used as a partner drug with dihydroartemisinin (DHA), exh...
A bioanalytical method for the analysis of piperaquine in human plasma using off-line solid-phase ex...
Pharmacokinetic differences between piperaquine (PQ) base and PQ tetraphosphate were investigated in...
The pharmacokinetic properties of piperaquine were investigated in 12 pregnant and 12 well-matched, ...
The pharmacokinetic properties of piperaquine were investigated in 12 pregnant and 12 well-matched, ...
Dihydroartemisinin-piperaquine is an effective drug in the treatment of Plasmodium falciparum and P....
The population pharmacokinetics of piperaquine in adults and children with uncomplicated Plasmodium ...
The population pharmacokinetics of piperaquine in adults and children with uncomplicated Plasmodium ...
One promising new Artemisinin-based combination therapies (ACTs) is dihydroartemisinin-piperaquine (...
BackgroundA considerable challenge in quantification of the antimalarial piperaquine in plasma is ca...
Purpose Dihydroartemisinin-piperaquine (DP) is a fixeddose artemisinin-based combination treatment. ...
PURPOSE: Dihydroartemisinin-piperaquine (DP) is a fixed-dose artemisinin-based combination treatment...
Piperaquine (PQ) is an antimalarial drug that is highly protein-bound. Variation in plasma protein c...
Malaria is one of the most common parasitic diseases in the world, with up to three million deaths a...
Dihydroartemisinin-piperaquine is being increasingly used as a first-line artemisinin combination tr...
Antimalarial piperaquine (PQ) is currently used as a partner drug with dihydroartemisinin (DHA), exh...
A bioanalytical method for the analysis of piperaquine in human plasma using off-line solid-phase ex...
Pharmacokinetic differences between piperaquine (PQ) base and PQ tetraphosphate were investigated in...
The pharmacokinetic properties of piperaquine were investigated in 12 pregnant and 12 well-matched, ...
The pharmacokinetic properties of piperaquine were investigated in 12 pregnant and 12 well-matched, ...
Dihydroartemisinin-piperaquine is an effective drug in the treatment of Plasmodium falciparum and P....
The population pharmacokinetics of piperaquine in adults and children with uncomplicated Plasmodium ...
The population pharmacokinetics of piperaquine in adults and children with uncomplicated Plasmodium ...
One promising new Artemisinin-based combination therapies (ACTs) is dihydroartemisinin-piperaquine (...